Risk prediction in diffuse large B-cell lymphoma improves when combining baseline PET features with interim PET response

Accurate detection of patients at high risk of treatment failure following first line immunochemotherapy in diffuse large B-cell lymphoma (DLBCL) is of paramount importance as patients might benefit from early treatment escalation. Recently, we introduced the International Metabolic Prognostic Inde...

Full description

Saved in:
Bibliographic Details
Main Authors: Jakoba J. Eertink, Martijn W. Heymans, Sanne E. Wiegers, Annelies L. Bes, Ulrich Duhrsen, Andreas Huttmann, Lars Kurch, Sally F. Barrington, George N. Mikhaeel, Pieternella J. Lugtenburg, Luca Ceriani, Emanuele Zucca, Tamas Gyorke, Sandor Czibor, Gerben J.C. Zwezerijnen, Ronald Boellaard, Josee M. Zijlstra, Christine Hanoun
Format: Article
Language:English
Published: Ferrata Storti Foundation 2025-05-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/12060
Tags: Add Tag
No Tags, Be the first to tag this record!